MGI Pharma MOGN New patents, anti cancer Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MGI Pharma MOGN New patents, anti cancer

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Russian Bear who wrote (675)	2/17/1998 12:25:00 PM
From: Biomaven	Read Replies (2) of 1826

Good news! I think its important that the approval appears to be for Sjogren's, not just for _Primary_ Sjogren's. This is a very large market (1 million patients according to the release) for this small a company. However, these are difficult patients to reach, as doctor (and dentist/dental hygienist) education is needed. Surely this market would be better (and more quickly) developed and penetrated by partnering with a big guy? Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next